课题基金 / 基金详情

项目摘要

项目成果

CHIEN-LIANG GLENN LIN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Cytoplasmic RNA oxidation is a prominent feature of vulnerable neurons in the brains of Alzheimer's disease (AD) patients. However, the role of RNA oxidation in the pathogenesis of AD is still unknown. We have recently developed a novel procedure to isolate and characterize oxidized RNA. We found that up to 50% of poly(A)+ mRNAs are oxidized in AD brains. Identification of oxidized mRNA species revealed that some mRNAs are more susceptible to oxidative damage; thus, RNA oxidation is not random but highly selective. Importantly, many identified oxidized mRNA species have been implicated in the pathogenesis of AD. Investigation of the consequence of oxidatively damaged mRNAs revealed that oxidized mRNA could not be translated properly leading to reduced protein expression and consequently, loss of normal protein function. Significantly, microinjection of oxidized mRNAs into neuronal cells leads to cell death, suggesting that increased RNA oxidation could lead to cell death. Furthermore, several lines of evidence suggest that RNA oxidation is an early event preceding cell death, not an artifact of dying cells. Taken these studies together, RNA oxidation itself is directly associated with neuronal deterioration instead of harmless epiphenomenona during the process of neurodegeneration. This is an important, yet understudied area. Further detailed investigation is needed. We hypothesize that oxidative damage to mRNA could result in protein malfunction, which could contribute to neuronal death in AD. In Aim 1, we propose to further identify oxidized mRNA species by cDNA microarray, to quantify the oxidation level for each oxidized mRNAs, and to investigate the proteins corresponding to the identified oxidized mRNA species in AD. This study will identify those highly oxidized mRNA species and determine whether proteins corresponding to those highly oxidized mRNA species are defective. In Aim 2, we propose to investigate the biological consequence of RNA oxidation. These studies will elucidate whether RNA oxidation plays a role in the pathogenesis of AD.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/s00018-010-0277-y
发表时间: 2010-06
期刊: CELLULAR AND MOLECULAR LIFE SCIENCES
影响因子: 8
作者: [Kong, Qiongman, Lin, Chien-liang Glenn]
通讯作者: Lin, Chien-liang Glenn
Development of a small-molecule that enhances tripartite synapses for Alzheimers disease
  • 批准号:
    10474460
  • 项目类别:
  • 资助金额:
    $148.9万
  • 财政年份:
    2020
  • 负责人:
    CHIEN-LIANG GLENN LIN
  • 依托单位:
Target identification of small molecule LDN/OSU-215111
  • 批准号:
    9885609
  • 项目类别:
  • 资助金额:
    $45.68万
  • 财政年份:
    2020
  • 负责人:
    CHIEN-LIANG GLENN LIN
  • 依托单位:
Development of a small-molecule that enhances tripartite synapses for Alzheimers disease
  • 批准号:
    10045319
  • 项目类别:
  • 资助金额:
    $155.25万
  • 财政年份:
    2020
  • 负责人:
    CHIEN-LIANG GLENN LIN
  • 依托单位:
Development of a small-molecule that enhances tripartite synapses for Alzheimers disease
  • 批准号:
    10263179
  • 项目类别:
  • 资助金额:
    $149.29万
  • 财政年份:
    2020
  • 负责人:
    CHIEN-LIANG GLENN LIN
  • 依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
  • 批准号:
    81000622
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2010
  • 负责人:
    梁胜
  • 依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
  • 批准号:
    31060293
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    26.0万元
  • 批准年份:
    2010
  • 负责人:
    郭亚芬
  • 依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究